Gleevec (Imatinib)

Gleevec, also known by its generic name imatinib, is a targeted cancer treatment used primarily for certain types of leukemia and other cancers, particularly chronic myeloid leukemia (CML). It works by blocking specific proteins that help cancer cells grow and divide, effectively slowing down or stopping the disease. Unlike traditional chemotherapy, which can affect many cells in the body, Gleevec selectively targets cancer cells, often resulting in fewer side effects. It represents a significant advancement in cancer therapy, allowing many patients to manage their condition more effectively and improve their quality of life.